Buy Celsentri Tablets Online

Buy Celsentri online with a valid prescription and compare current listed pricing, tablet strengths, and safety basics before you place an order. You can match Celsentri tablets to your prescribed strength, review access factors for US delivery from Canada, and check what matters at checkout. Celsentri contains maraviroc, an HIV-1 entry inhibitor used only with other antiretroviral medicines.

Celsentri Price and Available Options

The current listed Celsentri price is tied to the selected strength, quantity, and pack details shown on the product page. Before checkout, compare the tablet strength, total tablet count, and any available manufacturer or generic listing. This helps you avoid choosing a presentation that does not match your prescriber’s directions.

If generic maraviroc tablets are displayed separately, compare them with the brand listing line by line. Check the active ingredient, tablet strength, quantity supplied, and product origin when that information appears. For Celsentri cost planning, the most useful comparison is the full order total for the exact presentation your prescription names.

Quick tip: Match the selected listing to the prescription first, then compare totals.

How to Buy Celsentri Online

Choose the correct tablet presentation, confirm the quantity, and enter the order details exactly as they appear on your prescription. Keep your prescriber’s contact information available in case directions or product details need confirmation before dispensing. Prescription details may be checked with your prescriber when needed.

Some U.S. patients use this listing to order Celsentri from Canada while staying aligned with their prescribed HIV regimen. If you are comparing Celsentri without insurance, focus on the selected strength, quantity, and total checkout amount rather than a general estimate. Cash-pay access can be helpful, but the selected product still needs to match the treatment plan your clinician has already set.

Do not change strength, tablet count, or timing to make an order fit the listing. If the exact presentation is not available, ask your care team whether another maraviroc tablet option or a different antiretroviral plan is appropriate. The safest next step is always to keep the regimen medically coherent.

What It Treats and Who It Fits

Celsentri is an HIV medication used with other antiretroviral medicines for HIV-1 that is confirmed to be CCR5-tropic. CCR5-tropic means the virus uses the CCR5 co-receptor on immune cells to enter them. A tropism test helps confirm whether this entry pathway is present before treatment is selected.

This medicine is not used by itself and is not intended for HIV prevention before exposure. It also does not treat HIV that uses the CXCR4 pathway or dual/mixed tropism. Your care team may repeat testing if the virus is not responding as expected, because the viral entry pattern can affect whether maraviroc remains a useful option.

The HIV product category can help you keep related prescription options organized while you compare your prescribed medicines. Customers reviewing broader antiretroviral choices can also browse Antivirals for class-level product navigation.

Strengths, Dosing, and Tablet Details

Celsentri tablets are film-coated oral tablets. Commonly published presentations include Celsentri 150 mg and Celsentri 300 mg, though availability can vary by listing and supply. Generic maraviroc 150 mg or maraviroc 300 mg may appear separately when available through the product catalog.

Celsentri dosage is not chosen by preference at checkout. The prescriber sets the dose using your other medicines, kidney and liver factors, and the official product label. Strong CYP3A inhibitors or inducers can change maraviroc exposure, which is one reason tablet strength must match the written directions.

• 150 mg tablets: may be used in some regimens with strong CYP3A inhibitors.
• 300 mg tablets: often appear in standard tablet listings.
• Twice-daily use: common labeling uses oral doses with or without food.
• Combination therapy: companion antiretrovirals remain essential.

Swallow tablets whole with water unless your clinician gives different instructions. If you miss a dose, follow the missed-dose directions supplied with your medicine or ask your pharmacist. Do not double up to make up for a missed tablet unless a healthcare professional specifically tells you to do so.

How the Entry Inhibitor Works

Maraviroc is a CCR5 antagonist medication, also called an entry inhibitor. It binds to the CCR5 co-receptor on certain immune cells and may block CCR5-tropic HIV-1 from entering those cells. This mechanism is different from medicines that target viral enzymes, such as reverse transcriptase, protease, or integrase.

Because it targets a human co-receptor, this treatment only makes sense when testing shows the virus uses CCR5. The goal is to add a fully active option to a complete antiretroviral regimen. Your clinician will consider resistance history, current viral load, CD4 count, drug interactions, and tolerability before deciding where it fits.

Why it matters: Tropism testing helps prevent use when the virus is unlikely to respond.

Storage, Travel, and Delivery

Store the tablets at room temperature in the original container, away from excess heat and moisture. Keep the bottle tightly closed and out of reach of children and pets. Do not use tablets that are damaged, discolored, or past the labeled expiration date.

For travel, keep Celsentri tablets in labeled packaging and carry them in hand luggage. Bring a medication list and a copy of your prescription, especially when crossing borders or visiting a new clinic. Plan refills early so travel, lab appointments, or shipment handling do not interrupt your combination regimen.

Selected orders may use express shipping when available, but no delivery timing should replace refill planning. Country-of-origin details, when displayed, can be checked through Canada listings for recordkeeping. Keep the package label until you have confirmed the contents match your order and prescription.

Side Effects and Safety Points

Review safety details before checkout so you know what to monitor after the medicine arrives. Common side effects reported with maraviroc can include cough, upper respiratory symptoms, nausea, diarrhea, stomach discomfort, headache, dizziness, tiredness, rash, itching, and muscle or joint aches. Many symptoms are manageable, but persistent or worsening effects should be discussed with your care team.

• Allergic symptoms: rash, fever, swelling, or breathing trouble need urgent attention.
• Liver warning signs: yellow skin, dark urine, or severe fatigue can be serious.
• Skin reactions: blistering, mouth sores, or peeling skin require emergency care.
• Blood pressure effects: dizziness or fainting may reflect postural hypotension.
• Heart symptoms: chest pain or unusual shortness of breath needs prompt care.

Serious risks can include hepatotoxicity, severe skin or hypersensitivity reactions, postural hypotension, and cardiovascular events. Immune reconstitution syndrome may also occur after starting or changing antiretroviral therapy, as the immune system begins responding to hidden infections. This is one reason follow-up visits and lab monitoring matter after regimen changes.

Do not use Celsentri as a stand-alone HIV treatment. Skipping companion medicines, stopping suddenly, or taking doses inconsistently can affect the full regimen. If side effects make adherence difficult, contact your HIV care team before making changes.

Interactions, Monitoring, and Alternatives

Maraviroc is metabolized mainly by CYP3A. Strong CYP3A inhibitors, strong CYP3A inducers, and certain antiretroviral combinations can raise or lower drug levels. Your clinician may adjust the prescribed amount based on the full medication list, including supplements and non-HIV medicines.

Avoid St John’s wort because it can reduce levels of many medicines processed through CYP pathways. Use caution with medicines that lower blood pressure, because dizziness or fainting may be more likely in some patients. People with kidney impairment, liver disease, cardiovascular risk, or complex regimens need a careful medication review before treatment is selected.

Monitoring usually includes viral load, CD4 count, safety labs, and assessment for side effects. If virologic failure occurs, the care team may repeat resistance or tropism testing. Alternatives may come from other antiretroviral classes, such as integrase inhibitors, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, or protease inhibitors, depending on prior treatment history and resistance results.

Authoritative Sources

These sources support label-aligned use, class information, and safety context:

• Official regulator overview: European Medicines Agency Celsentri
• Canadian patient resource: CATIE Maraviroc
• Canadian product monograph: Celsentri Product Monograph

Use the official label and your clinician’s instructions when product information, dose directions, or safety questions differ from general summaries. Keep your HIV care team informed about every medicine and supplement you use.

This content is for informational purposes only and is not a substitute for professional medical advice.